Autopsy report · NCT01286090

An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

“Sponsor request”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 years 6 months after it had already started.
• Ran for about 3 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Sponsor type

Industry

Conditions

Gastroparesis; Diabetes Mellitus

Interventions

Cisapride; Placebo

Participants

4

Trials that died the same way

• A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
  “requested by sponsor” (92% match in meaning)
• A Study to Evaluate ART101 in Adult Participants With Hypertension
  “At Sponsor's Request” (86% match in meaning)
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
  “Due to sponsor request” (86% match in meaning)
• Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed
  “Sponsor related” (81% match in meaning)
• Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
  “Sponsor decision” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.